These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The world's experience with facial transplantation: what have we learned thus far?
    Author: Gordon CR, Siemionow M, Papay F, Pryor L, Gatherwright J, Kodish E, Paradis C, Coffman K, Mathes D, Schneeberger S, Losee J, Serletti JM, Hivelin M, Lantieri L, Zins JE.
    Journal: Ann Plast Surg; 2009 Nov; 63(5):572-8. PubMed ID: 19806039.
    Abstract:
    The objective of this review article is to summarize the published details and media citations for all seven face transplants performed to date to point out deficiencies in those reports so as to provide the basis for examining where the field of face transplantation stands, and to act as a stimulus to enhance the quality of future reports and functional outcomes. Overall long-term function of facial alloflaps has been reported satisfactorily in all seven cases. Sensory recovery ranges between 3 and 6 months, and acceptable motor recovery ranges between 9 and 12 months. The risks and benefits of facial composite tissue allotransplantation, which involves mandatory lifelong immunosuppression analogous to kidney transplants, should be deliberated by each institution's multidisciplinary face transplant team. Face transplantation has been shown thus far to be a viable option in some patients suffering severe facial deficits which are not amenable to modern-day reconstructive technique.
    [Abstract] [Full Text] [Related] [New Search]